Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Abstract

Fremanezumab effectively prevents CM in Japanese and Korean patients and was well tolerated. No safety signal was detected.